Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…
Annual Drug Patent Expirations for APIDRA Apidra is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Sanofi Aventis drug APIDRA appeared first on DrugPaten…
Annual Drug Patent Expirations for ADMELOG+SOLOSTAR Admelog Solostar is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Sanofi-aventis Us drug ADMELOG SOLOS…
Annual Drug Patent Expirations for ADMELOG+SOLOSTAR Admelog Solostar is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Sanofi-aventis Us drug ADMELOG SOLOS…
Annual Drug Patent Expirations for ADMELOG Admelog is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Sanofi-aventis Us drug ADMELOG appeared first …
Annual Drug Patent Expirations for ADMELOG Admelog is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Sanofi-aventis Us drug ADMELOG appeared first …
Annual Drug Patent Expirations for NETSPOT Netspot is a drug marketed by Aaa Usa Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Aaa Usa drug NETSPOT appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Novartis drug TASIGNA appeared first on D…
Annual Drug Patent Expirations for APADAZ Apadaz is a drug marketed by Kempharm and is included in one NDA. The generic ingredient in APADAZ is acetaminophen; benzhydrocodone hydrochloride. Additional details…
The post New patent for Kempharm dru…
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from five suppliers. There are…
The post New patent for Glaxo Grp drug FLOVENT HFA appeared first on DrugPa…